Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

52 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Value of Somatostatin Receptor PET/CT in Patients With MEN1 at Various Stages of Their Disease.
Mennetrey C, Le Bras M, Bando-Delaunay A, Al-Mansour L, Haissaguerre M, Batisse-Lignier M, Ouvrard E, Ansquer C, Walter T, de Mestier L, Kelly A, Tlili G, Giraud S, North MO, Odou MF, Goichot B, Cuny T, Loundou A, Romanet P, Imperiale A, Taïeb D. Mennetrey C, et al. Among authors: ansquer c. J Clin Endocrinol Metab. 2022 Apr 19;107(5):e2056-e2064. doi: 10.1210/clinem/dgab891. J Clin Endocrinol Metab. 2022. PMID: 34940846
Sensitivity and prognostic value of positron emission tomography with F-18-fluorodeoxyglucose and sensitivity of immunoscintigraphy in patients with medullary thyroid carcinoma treated with anticarcinoembryonic antigen-targeted radioimmunotherapy.
Oudoux A, Salaun PY, Bournaud C, Campion L, Ansquer C, Rousseau C, Bardet S, Borson-Chazot F, Vuillez JP, Murat A, Mirallié E, Barbet J, Goldenberg DM, Chatal JF, Kraeber-Bodéré F. Oudoux A, et al. Among authors: ansquer c. J Clin Endocrinol Metab. 2007 Dec;92(12):4590-7. doi: 10.1210/jc.2007-0938. Epub 2007 Sep 18. J Clin Endocrinol Metab. 2007. PMID: 17878252 Clinical Trial.
18-F FDG-PET in the staging of lymphocyte-predominant Hodgkin's disease.
Ansquer C, Hervouët T, Devillers A, de Guibert S, Gastinne T, Le Gouill S, Garin E, Moreau A, Kraeber-Bodéré F, Lamy T. Ansquer C, et al. Haematologica. 2008 Jan;93(1):128-31. doi: 10.3324/haematol.11661. Haematologica. 2008. PMID: 18166797 Free article.
¹⁸F-FDG PET predicts survival after pretargeted radioimmunotherapy in patients with progressive metastatic medullary thyroid carcinoma.
Salaun PY, Campion L, Ansquer C, Frampas E, Mathieu C, Robin P, Bournaud C, Vuillez JP, Taieb D, Rousseau C, Drui D, Mirallié E, Borson-Chazot F, Goldenberg DM, Chatal JF, Barbet J, Kraeber-Bodéré F. Salaun PY, et al. Among authors: ansquer c. Eur J Nucl Med Mol Imaging. 2014 Aug;41(8):1501-10. doi: 10.1007/s00259-014-2772-0. Epub 2014 May 8. Eur J Nucl Med Mol Imaging. 2014. PMID: 24806110 Clinical Trial.
Performance of 18F-FDG PET/CT in the Characterization of Adrenal Masses in Noncancer Patients: A Prospective Study.
Guerin C, Pattou F, Brunaud L, Lifante JC, Mirallié E, Haissaguerre M, Huglo D, Olivier P, Houzard C, Ansquer C, Hindié E, Loundou A, Archange C, Tabarin A, Sebag F, Baumstarck K, Taïeb D. Guerin C, et al. Among authors: ansquer c. J Clin Endocrinol Metab. 2017 Jul 1;102(7):2465-2472. doi: 10.1210/jc.2017-00254. J Clin Endocrinol Metab. 2017. PMID: 28431167
Novel PET tracers: added value for endocrine disorders.
Bergeret S, Charbit J, Ansquer C, Bera G, Chanson P, Lussey-Lepoutre C. Bergeret S, et al. Among authors: ansquer c. Endocrine. 2019 Apr;64(1):14-30. doi: 10.1007/s12020-019-01895-z. Epub 2019 Mar 14. Endocrine. 2019. PMID: 30875057 Review.
52 results